Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded in August 2003 and is headquartered in Radnor, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Marinus Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Marinus Pharmaceuticals Inc market cap is $29.63M.
What is the 52-week high for Marinus Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Marinus Pharmaceuticals Inc 52 week high is $10.50 as of September 26, 2025.
What is the 52-week low for Marinus Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Marinus Pharmaceuticals Inc 52 week low is $0.2202 as of September 26, 2025.
What is Marinus Pharmaceuticals Inc stock price today?
Marinus Pharmaceuticals Inc stock price today is $0.55.
What was Marinus Pharmaceuticals Inc stock price yesterday?
Marinus Pharmaceuticals Inc stock price yesterday was $0.5495.
What is the PE ratio of Marinus Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Marinus Pharmaceuticals Inc’s P/E ratio is -0.22.
What is the Price-to-Book ratio of Marinus Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Marinus Pharmaceuticals Inc P/B ratio is -0.4548.
What is the 50-day moving average of Marinus Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Marinus Pharmaceuticals Inc 50-day moving average is $0.4561.
